查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
临床试验管理服务市场:规模，占有率，趋势分析报告:各类服务，各业界，各适应症，各地区，各市场区隔预测(2022年～2030年)
市场调查报告书
商品编码
1171130

临床试验管理服务市场:规模，占有率，趋势分析报告:各类服务，各业界，各适应症，各地区，各市场区隔预测(2022年～2030年)

Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services (Clinical Trial Monitoring, Regulatory Submissions), By Industry, By Indication, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 275 Pages | 商品交期: 2-10个工作天内

价格

全球临床试验管理服务的市场规模在2022年～2030年的预测期间内预计将以7.5％的年复合成长率扩大，到2030年前将达到521亿美元。

临床试验活动的外包倾向提升，先进性治疗方法研究开发的增加，临床试验的世界化等，是推动市场成长的主要原因。

本报告提供全球临床试验管理服务市场相关调查，提供市场现状，以及各类服务，各业界，各适应症，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 调查手法和范围

第2章 摘要整理

第3章 临床试验管理服务市场变数，趋势，范围

  • 市场系列预测
  • 渗透与成长预测的製图
  • 市场动态
    • 推动市场要素分析
    • 阻碍市场要素分析
    • 渗透与成长预测的製图
    • COVID-19影响与復苏的分析
    • 主要交易和策略性联盟分析
    • 产业分析- 波特的五力分析
    • 大环境分析

第4章 临床试验管理服务市场:各类服务市场区隔分析

  • 临床试验管理服务市场:定义和范围
  • 临床试验管理服务市场:各类服务市场占有率分析，2021年及2030年
    • 临床试验监测
    • 法规当局的缴交
    • 临床试验资料管理
    • 医学写作
    • 网站管理和监视
    • 其他

第5章 临床试验管理服务市场:各业界市场区隔分析

  • 临床试验管理服务市场:定义和范围
  • 临床试验管理服务市场:各业界市场占有率分析，2021年及2030年
    • 医药品
    • 生物医药品
    • 医疗设备

第6章 临床试验管理服务市场:各适应症各市场区隔分析

  • 临床试验管理服务市场:定义和范围
  • 临床试验管理服务市场:各适应症市场占有率分析，2021年及2030年
    • 免疫学
    • 血液学
    • 肿瘤学
    • 神经学
    • 皮肤科
    • 其他

第7章 临床试验管理服务市场:各地区分析

  • 临床试验管理服务:各地区市场占有率分析，2021年及2030年
  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第8章 竞争情形

  • 临床试验管理服务市场:企业的市场占有率分析，2021年及2030年
  • 企业简介
    • SGS
    • LabCorp
    • IQVIA, Inc.
    • Syneous Health
    • Atlantic Research Group
    • ICON PLC
    • Clinical Trial &Consulting Services
    • Charles River Laboratories
    • Med pace
    • Wuxi Apptec
Product Code: GVR-4-68039-993-8

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 52.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.5% from 2022 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

  • The clinical trial monitoring segment dominated the market with a revenue share of 31.6% in 2021. Technological advancement in trial monitoring is one of the key factors driving the growth of the market.
  • The oncology segment is anticipated to hold the highest market share of 31.0% in 2021 in the clinical trial management services market. High shares of the segment are majorly due to the increasing cases of cancer across the globe.
  • Based on industry, pharmaceuticals accounted for the largest market share of 38.9% in 2021. The companies have adopted technologies such as cloud computing and AI to improve patient engagement and reduce trial failures to drive market growth.
  • Asia Pacific is projected to witness the fastest CAGR-driven growth of 8.5% during the forecast period. Factors such as the cheap labor cost, a diverse patient pool, lowered costs of clinical trial activities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Services
    • 1.1.2. Industry
    • 1.1.3. Indication
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing technological advancement in the clinical trial monitoring services
      • 3.3.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
      • 3.3.1.3. Growth in the number of outsourced projects related to clinical trial management services
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High cost associated with clinical trial management services
      • 3.3.2.2. Stringent regulatory policies for clinical trial management services
    • 3.3.3. Penetration & Growth Prospect Mapping
    • 3.3.4. Covid-19 Impact & Recovery Analysis
    • 3.3.5. Major Deals and Strategic Alliances Analysis
    • 3.3.6. Industry Analysis - Porter's Five Forces
    • 3.3.7. PESTLE Analysis

Chapter 4. Clinical Trial Management Services Market: Services Segment Analysis

  • 4.1. Clinical Trial Management Services Market: Definition & Scope
  • 4.2. Clinical Trial Management Services Market: Services Market Share Analysis, 2021 & 2030
    • 4.2.1. Clinical Trial Monitoring
      • 4.2.1.1. Clinical Trial Monitoring Market, 2018 - 2030 (USD Million)
    • 4.2.2. Regulatory Submissions
      • 4.2.2.1. Regulatory Submissions Market, 2018 - 2030 (USD Million)
    • 4.2.3. Clinical Trial Data Management
      • 4.2.3.1. Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
    • 4.2.4. Medical Writing
      • 4.2.4.1. Medical Writing Market, 2018 - 2030 (USD Million)
    • 4.2.5. Site management & monitoring
      • 4.2.5.1. Site management & monitoring Market, 2018 - 2030 (USD Million)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Industry Segment Analysis

  • 5.1. Clinical Trial Management Services Market: Definition & Scope
  • 5.2. Clinical Trial Management Services Market: Industry Market Share Analysis, 2021 & 2030
    • 5.2.1. Pharmaceuticals
      • 5.2.1.1. Pharmaceuticals Market, 2018 - 2030 (USD Million)
    • 5.2.2. Biopharmaceuticals
      • 5.2.2.1. Biopharmaceuticals Market, 2018 - 2030 (USD Million)
    • 5.2.3. Medical Devices
      • 5.2.3.1. Medical Devices Market, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: Indication Segment Analysis

  • 6.1. Clinical Trial Management Services Market: Definition & Scope
  • 6.2. Clinical Trial Management Services Market: Indication Market Share Analysis, 2021 & 2030
    • 6.2.1. Immunology
      • 6.2.1.1. Immunology Market, 2018 - 2030 (USD Million)
    • 6.2.2. Hematology
      • 6.2.2.1. Hematology Market, 2018 - 2030 (USD Million)
    • 6.2.3. Oncology
      • 6.2.3.1. Oncology Market, 2018 - 2030 (USD Million)
    • 6.2.4. Neurology
      • 6.2.4.1. Neurology Market, 2018 - 2030 (USD Million)
    • 6.2.5. Dermatology
      • 6.2.5.1. Oncology Market, 2018 - 2030 (USD Million)
    • 6.2.6. Others
      • 6.2.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Analysis

  • 7.1. Clinical Trial Management Services: Regional market share analysis, 2021 & 2030
  • 7.2. North America
    • 7.2.1. U.S. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. France Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.3. India
      • 7.4.3.1. India Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Japan Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Argentina Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Arabia
      • 7.6.3.1. South Africa Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Clinical Trial Management Services Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Clinical Trial Management Services: Company market share analysis, 2021 & 2030
  • 8.2. Company Profiles
    • 8.2.1. SGS
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Service benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. LabCorp
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Service benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. IQVIA, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Service benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Syneous Health
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Service benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Atlantic Research Group
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Service benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. ICON PLC
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Service benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Clinical Trial & Consulting Services
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Service benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Charles River Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Service benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Med pace
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Service benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Wuxi Apptec
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Service benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Clinical trial management services market snapshot (2021)
  • Fig. 10 Clinical trial management services market segmentation
  • Fig. 11 Heat map analysis
  • Fig. 12 Parent market outlook
  • Fig. 13 Ancillary market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Clinical trial management services market services outlook: Segment dashboard
  • Fig. 20 Clinical trial management services market: Services movement analysis
  • Fig. 21 Clinical trial monitoring market, 2018 - 2030 (USD Million)
  • Fig. 22 Regulatory submissions market, 2018 - 2030 (USD Million)
  • Fig. 23 Clinical trial data management market, 2018 - 2030 (USD Million)
  • Fig. 24 Medical writing market, 2018 - 2030 (USD Million)
  • Fig. 25 Site management & monitoring market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical trial management services market industry outlook: Segment dashboard
  • Fig. 28 Clinical trial management services market: Industry movement analysis
  • Fig. 29 Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 30 Biopharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 31 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical trial management services market indication outlook: Segment dashboard
  • Fig. 33 Clinical trial management services market: Indication movement analysis
  • Fig. 34 Immunology testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Hematology market, 2018 - 2030 (USD Million)
  • Fig. 36 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 37 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 38 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 39 Regional market: Key takeaways
  • Fig. 40 Clinical trial management services market: Regional movement analysis
  • Fig. 41 North America. market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe market, 2018 - 2030 (USD Million)
  • Fig. 45 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany market, 2018 - 2030 (USD Million)
  • Fig. 47 France market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market, 2018 - 2030 (USD Million)
  • Fig. 52 China market, 2018 - 2030 (USD Million)
  • Fig. 53 India market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 59 MEA market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE market, 2018 - 2030 (USD Million)